Yiding Chen

3.3k total citations · 1 hit paper
86 papers, 2.0k citations indexed

About

Yiding Chen is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Yiding Chen has authored 86 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 34 papers in Oncology and 23 papers in Cancer Research. Recurrent topics in Yiding Chen's work include Breast Cancer Treatment Studies (11 papers), BRCA gene mutations in cancer (8 papers) and HER2/EGFR in Cancer Research (8 papers). Yiding Chen is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), BRCA gene mutations in cancer (8 papers) and HER2/EGFR in Cancer Research (8 papers). Yiding Chen collaborates with scholars based in China, United States and India. Yiding Chen's co-authors include Jiaojiao Zhou, Shu Zheng, Danfeng Lin, Lesang Shen, Kun Zhang, Fangfang Zhu, Qi Yang, Jinfan Li, Dan Zhou and Meng Luo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Yiding Chen

83 papers receiving 2.0k citations

Hit Papers

Circulating tumor cells: biology and clinical significance 2021 2026 2022 2024 2021 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiding Chen China 21 975 710 526 247 226 86 2.0k
Paolo Ubezio Italy 29 1.4k 1.4× 628 0.9× 488 0.9× 235 1.0× 156 0.7× 111 2.5k
Nhu‐An Pham Canada 24 980 1.0× 660 0.9× 381 0.7× 369 1.5× 121 0.5× 56 1.8k
Laurent Poulain France 29 1.6k 1.6× 645 0.9× 869 1.7× 212 0.9× 101 0.4× 79 2.6k
Dmitri Mouradov Australia 17 1.4k 1.4× 535 0.8× 776 1.5× 216 0.9× 75 0.3× 32 2.4k
Min Xiao China 24 1.6k 1.6× 624 0.9× 601 1.1× 208 0.8× 165 0.7× 73 3.0k
Mark J. Suto United States 30 1.5k 1.6× 531 0.7× 320 0.6× 181 0.7× 111 0.5× 88 2.6k
Feifei Xu China 24 1.2k 1.2× 362 0.5× 352 0.7× 132 0.5× 157 0.7× 76 1.8k
Sukyung Woo United States 25 1.0k 1.1× 460 0.6× 458 0.9× 377 1.5× 250 1.1× 63 2.2k
José M.A. Moreira Denmark 31 1.8k 1.9× 656 0.9× 670 1.3× 210 0.9× 138 0.6× 79 2.8k
Martin P. Barr Ireland 26 1.4k 1.5× 910 1.3× 728 1.4× 291 1.2× 102 0.5× 65 2.4k

Countries citing papers authored by Yiding Chen

Since Specialization
Citations

This map shows the geographic impact of Yiding Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiding Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiding Chen more than expected).

Fields of papers citing papers by Yiding Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiding Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiding Chen. The network helps show where Yiding Chen may publish in the future.

Co-authorship network of co-authors of Yiding Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yiding Chen. A scholar is included among the top collaborators of Yiding Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiding Chen. Yiding Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Zhiyun, Ting Ma, Huihui Chen, et al.. (2024). Clinical significance of circulating tumor DNA in neoadjuvant-treated HER2-negative luminal B breast cancer.. Journal of Clinical Oncology. 42(16_suppl). e12616–e12616.
2.
Geng, Cuizhi, Quchang Ouyang, Haibo Wang, et al.. (2024). Safety and patient-reported outcomes in patients with hormone receptor-positive, HER2-negative advanced breast cancer treated with CDK4/6 inhibitors in China: A cross-sectional study.. Journal of Clinical Oncology. 42(16_suppl). 1054–1054. 1 indexed citations
3.
Hu, Zhengfang, Kaiyue Wang, Yunxiang Zhou, et al.. (2024). Why does HER2-positive breast cancer metastasize to the brain and what can we do about it?. Critical Reviews in Oncology/Hematology. 195. 104269–104269. 3 indexed citations
4.
Zheng, Yabing, Wen‐Ming Cao, Xiying Shao, et al.. (2023). Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial. Nature Communications. 14(1). 8314–8314. 10 indexed citations
5.
Wang, Lan, et al.. (2023). Effect of Bifidobacterium on osteoclasts: TNF-α/NF-κB inflammatory signal pathway-mediated mechanism. Frontiers in Endocrinology. 14. 1109296–1109296. 36 indexed citations
6.
Lu, Henglei, et al.. (2022). HMGN5 Escorts Oncogenic STAT3 Signaling by Regulating the Chromatin Landscape in Breast Cancer Tumorigenesis. Molecular Cancer Research. 20(12). 1724–1738. 4 indexed citations
7.
Yang, Shuhua, Yuehong Wang, Jiaojiao Zhou, et al.. (2022). Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells. Oncogene. 41(18). 2624–2637. 11 indexed citations
8.
Luo, Meng, Huihui Chen, Hao Deng, et al.. (2022). Postmastectomy Radiotherapy After Neoadjuvant Chemotherapy in cT1-2N+ Breast Cancer Patients: A Single Center Experience and Review of Current Literature. Frontiers in Oncology. 12. 881047–881047. 2 indexed citations
9.
Zhou, Qian, et al.. (2022). Efficacy of cinnamon supplementation on glycolipid metabolism in T2DM diabetes: A meta-analysis and systematic review. Frontiers in Physiology. 13. 960580–960580. 16 indexed citations
11.
Zhou, Jiaojiao, Xuan Zhu, Shijie Wu, et al.. (2020). Epithelial-mesenchymal transition status of circulating tumor cells in breast cancer and its clinical relevance. Cancer Biology and Medicine. 17(1). 169–180. 23 indexed citations
12.
Shen, Lesang, Danfeng Lin, Xiaoyi Li, et al.. (2020). Ferroptosis in Acute Central Nervous System Injuries: The Future Direction?. Frontiers in Cell and Developmental Biology. 8. 594–594. 76 indexed citations
13.
Ye, Sen, Xiaoli Liu, Jingyi Feng, et al.. (2019). SET Domain–Containing Protein 4 Epigenetically Controls Breast Cancer Stem Cell Quiescence. Cancer Research. 79(18). 4729–4743. 47 indexed citations
14.
Wang, Wen, et al.. (2019). The Neuropeptide Vasoactive Intestinal Peptide Levels in Serum are Inversely Related to Disease Severity of Postmenopausal Osteoporosis: A Cross-Sectional Study. Genetic Testing and Molecular Biomarkers. 23(7). 480–486. 11 indexed citations
15.
Wan, Fangping, Jun Zhou, Xin Chen, et al.. (2019). Overexpression and mutation of ZNF384 is associated with favorable prognosis in breast cancer patients. Translational Cancer Research. 8(3). 779–787. 7 indexed citations
16.
Xue, Yue, Lihua Lai, Wenwen Lian, et al.. (2018). SOX9/FXYD3/Src Axis Is Critical for ER+ Breast Cancer Stem Cell Function. Molecular Cancer Research. 17(1). 238–249. 43 indexed citations
17.
Zhou, Jiaojiao, Xuan Zhu, Meng Luo, et al.. (2017). Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer. Breast Cancer Research and Treatment. 166(3). 865–873. 19 indexed citations
18.
Chen, Yiding, et al.. (2014). Granular cell tumor of the breast during lactation: A case report and review of the literature. Oncology Letters. 8(6). 2565–2568. 1 indexed citations
19.
Chen, Yiding, et al.. (2009). Combined oxidized cellulose and cyanoacrylate glue in the management of severe presacral bleeding. Surgery Today. 39(11). 1016–1017. 8 indexed citations
20.
Qiu, Fuming, Jiekai Yu, Yiding Chen, et al.. (2009). Mining novel biomarkers for prognosis of gastric cancer with serum proteomics. Journal of Experimental & Clinical Cancer Research. 28(1). 126–126. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026